Encysive Pharmaceuticals, Inc.
Records under this name other than patents Encysive Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Encysive Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,972,296 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors Term ended Term ended May 5, 2020 · USPTO record | Term ended | Term ended May 5, 2020 | USPTO record |
| US 6,194,448 | N, N-disubstituted amides that inhibit the binding of integrins to their receptors Term ended Term ended Oct 14, 2019 · USPTO record | Term ended | Term ended Oct 14, 2019 | USPTO record |
| US 6,262,084 | Compounds that inhibit the binding of integrins to their receptors Term ended Term ended Oct 14, 2019 · USPTO record | Term ended | Term ended Oct 14, 2019 | USPTO record |
| US 6,096,773 | Compounds that inhibit the binding of integrins to their receptors Term ended Term ended Apr 15, 2019 · USPTO record | Term ended | Term ended Apr 15, 2019 | USPTO record |
| US 7,812,038 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors Lapsed on the fee record Ended Oct 12, 2018 · USPTO record | Lapsed on the fee record | Ended Oct 12, 2018 | USPTO record |
| US 6,432,994 | Sulfonamides for treatment of endothelin-mediated disorders Term ended Term ended Apr 28, 2017 · USPTO record | Term ended | Term ended Apr 28, 2017 | USPTO record |
| US 6,030,991 | Benzenesulfonamides and the use thereof to modulate the activity of endothelin Term ended Term ended Dec 6, 2016 · USPTO record | Term ended | Term ended Dec 6, 2016 | USPTO record |
| US 8,178,699 | Modulators of CCR9 receptor and methods of use thereof Lapsed on the fee record Ended May 15, 2016 · USPTO record | Lapsed on the fee record | Ended May 15, 2016 | USPTO record |
| US 6,723,711 | Propanoic acid derivatives that inhibit the binding of integrins to their receptors Lapsed on the fee record Ended Apr 20, 2016 · USPTO record | Lapsed on the fee record | Ended Apr 20, 2016 | USPTO record |
| US 6,686,382 | Sulfonamides and derivatives thereof that modulate the activity of endothelin Lapsed on the fee record Ended Feb 3, 2016 · USPTO record | Lapsed on the fee record | Ended Feb 3, 2016 | USPTO record |